替代N的天然甲胺衍生物的ACHE抑制活性
Mariyana Atanasova1, Georgi Stavrakov2, Irena Philipova3
1Faculty of Pharmacy, Medical University of Sofia, 2 Dunav Str., 1000 Sofia, Bulgaria.
加兰他胺衍生物在阿尔茨海默氏症治疗方面表现有前途. N-(2'-methyl) allylnorgalanthamine是一种强大的乙胆酶抑制剂,比甲胺有效33倍,因此需要进一步进行体内研究.
科学领域:
- 药用化学 医学化学
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 加兰他是一种已批准的阿尔茨海默病治疗药物,向乙胆化酶 (AChE).
- 探索胺衍生物可以导致新型ACHE抑制剂.
- 从N-诺格兰胺中合成N-乙诺格兰胺 (纳西辛) 和N-(2 eal) 基诺格兰胺.
研究的目的:
- 通过使用先进的二维NMR技术,修改纳西辛的NMR数据.
- 为了评估合成的甲胺衍生物的ACHE抑制活性.
- 评估N-(2eal) 基甲胺作为阿尔茨海默病治疗剂的潜力.
主要方法:
- 合成N-乙诺加胺和N-(2 eal) 全诺加胺.
- 通过2DH和H-C相关性实验对纳西辛的NMR数据的修订.
- 在体外的ACHE抑制试验,在式对接和ADME预测.
主要成果:
- 对纳西辛的NMR数据进行了修订,证实了它的结构.
- 与加兰他胺相比,N-乙诺加兰他胺和N-甲基诺加兰他胺显示了较低的ACHE抑制 (分别低于4倍和43倍).
- N-(2 eal) allylnorgalanthamine 显示出显著的 AChE 抑制作用,其效果是 galanthamine 的 33 倍.
结论:
- N-(2 eal) allylnorgalanthamine 是一种非常强大的天然 AChE 抑制剂.
- 这种衍生物显示出作为阿尔茨海默病潜在治疗剂的重大前景.
- 需要进一步的体内研究来证实N-(2eal) 基诺加兰胺的治疗适用性.
更多相关视频
10:24NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
Published on: June 30, 2019
09:04A Direct, Early Stage Guanidinylation Protocol for the Synthesis of Complex Aminoguanidine-containing Natural Products
Published on: September 9, 2016
相关概念视频
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
The direct-acting...
